Gujarat Kidney And Super Speciality Limited

HealthcareHealthcareHealthcare ServicesHospital

Ask AI

Key metrics

Price as of 2026-07-17

Stock price
₹128.36
Market cap
1,012 Cr
Stock P/E
67.0
P/B
3.97

Sign in for full ratios and TTM. Learn about these metrics →

Share price

NSE closing price from historical market data.

Loading price history…

Statement tables · Consolidated

Switches quarterly, P&L, balance sheet, and cash flow. Key metrics and ratios stay on consolidated when available.

Amounts in ₹ Cr · NSE preferred when both exchanges report the same period · tap + to expand rows

Quarterly results

Quarterly · ₹ Cr · tap + rows to expand

MetricSept 2025Dec 2025Mar 2026
Sales13 Cr23 Cr31 Cr
Operating expenses (approx.)8 Cr16 Cr24 Cr
EBITDA5 Cr7 Cr7 Cr
OPM %40.3%29.9%22.9%
Other income0.09 Cr0.06 Cr0.71 Cr
Interest0.28 Cr0.60 Cr0.82 Cr
Depreciation0.90 Cr1 Cr2 Cr
Profit before tax4 Cr5 Cr5 Cr
Tax %28.6%26.3%-3.0%
Net profit3 Cr4 Cr5 Cr
EPS (₹)₹0.52₹0.52₹0.81

Profit & loss (annual)

Annual · last column is TTM · ₹ Cr · tap + to expand

MetricMar 2026TTM
Sales82 CrSign in for TTM
Operating expenses (approx.)54 CrSign in for TTM
EBITDA28 CrSign in for TTM
OPM %33.9%Sign in for TTM
Other income0.87 CrSign in for TTM
Interest2 CrSign in for TTM
Depreciation5 CrSign in for TTM
Profit before tax21 CrSign in for TTM
Tax %20.8%Sign in for TTM
Net profit17 CrSign in for TTM
EPS (₹)₹2.49Sign in for TTM
Dividend payout %0.0%Sign in for TTM
Sign in for TTM

Trailing twelve months totals and margin rows

Balance sheet

Annual · ₹ Cr · tap + rows to expand

MetricMar 2026
Equity capital16 Cr
Reserves237 Cr
Borrowings14 Cr
Other liabilities29 Cr
Total liabilities298 Cr
Fixed assets (net)27 Cr
CWIP
Investments0.0000 Cr
Other assets105 Cr
Total assets298 Cr

Cash flows

Annual · ₹ Cr · tap + rows to expand · last column includes FCF

MetricMar 2026
Cash from operating activity-4 Cr
Cash from investing-214 Cr
Cash from financing228 Cr
Net cash flow11 Cr
Free cash flow (OCF − Capex)-15 Cr

Ratios

Ratios as reported or derived per annual period.

MetricMar 2026
ROCE %8.6%
ROE %6.1%
Debtor days
Inventory days82
Days payable
Cash conversion cycle82
Debt / equity0.05
Current ratio3.76
Net debt / EBITDA0.02

Compare with peers

Loading peers…